Khan, Samer R. http://orcid.org/0000-0002-8098-1907
Yaqub, Amber
Ikram, M. Kamran
van Hagen, P. Martin
Peeters, Robin P.
Dalm, Virgil A. S. H.
Chaker, Layal
Ikram, M. Arfan
Funding for this research was provided by:
Takeda Pharmaceutical Company (IIR-NLD-002671)
Article History
Received: 11 August 2022
Accepted: 6 September 2022
First Online: 19 September 2022
Declarations
:
: The authors declare that they have no conflict of interest.
: The Rotterdam Study has been approved by the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272-159521-PG). The Rotterdam Study Personal Registration Data collection is filed with the Erasmus MC Data Protection Officer under registration number EMC1712001. The Rotterdam Study has been entered into the Netherlands National Trial Register (NTR; ExternalRef removed) and into the WHO International Clinical Trials Registry Platform (ICTRP; ExternalRef removed) under shared catalog number NL6645/NTR6831.
: All participants provided written informed consent to participate in the study and to have their information obtained from treating physicians.